Skip to content

Performance of an Investigational Blood Glucose Monitoring System in a Clinical Setting

Clinical Trial Protocol for Ninja 2 System With TATSU Sensor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01268267
Enrollment
94
Registered
2010-12-30
Start date
2010-12-31
Completion date
2010-12-31
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study is to evaluate the performance and acceptability of an investigational blood glucose monitoring system, which includes meter and sensor strip.

Interventions

Untrained subjects with diabetes performed Blood Glucose(BG) tests from the subject's capillary blood obtained from fingerstick, palm, and forearm using the Ninja 2 investigational meter and an investigational sensor. All BG results were compared to a reference laboratory glucose method. Subjects' success at performing basic tasks using only the User Guide were rated by study staff.

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females, 18 years of age and above * Type 1 or type 2 diabetes * Currently self-testing blood glucose at home at least twice daily * Able to speak, read, and understand English * Willing to complete all study procedures

Exclusion criteria

* Currently Pregnant * Hemophilia or any other bleeding disorder * Employee of competitive medical device company * Cognitive disorder or other condition which, in the opinion of the investigator, would put the person at risk or seriously compromise the integrity of the study

Design outcomes

Primary

MeasureTime frameDescription
Numbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 20mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method2 hoursSubjects with diabetes tested subject fingerstick blood using an investigational blood glucose monitoring system (BGMS), which included an investigational meter and sensor. BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 20 mg/dL (for reference BG results \<75mg/dL) or +/- 5 to 20% (for reference BG results \>=75mg/dL) of the reference method results.

Secondary

MeasureTime frameDescription
Numbers of Palm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method2 hoursSubjects with diabetes used an investigational blood glucose monitoring system (BGMS) with subject capillary blood obtained from the palm. BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 20 mg/dL (for reference BG results \<75mg/dL) or +/- 5% to 20% (for reference BG results \>=75mg/dL) of the reference method results.
Number of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)2 hoursSubjects reviewed the instructions for use (User Guide and Quick Reference Guide) to learn to use the system. Study staff then observed and rated the subjects (1 to 4) on their success at performing the tasks. Scale: 1.Success in performing tasks correctly without assistance. 2.Successful with additional review of User Guide. 3.Successful with additional review and study staff assist similar to review of a specific function during a Customer Service call. 4.Subject did not perform task correctly and study staff intervention was required.
Numbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method2 hoursSubjects with diabetes used an investigational blood glucose monitoring system (BGMS) with subject capillary blood obtained from the forearm. BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 20 mg/dL (for reference BG results \<75mg/dL) or +/- 5% to 20% (for reference BG results \>=75mg/dL) of the reference method results.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intended Users of the System
Untrained subjects with diabetes use an investigational blood glucose monitoring system.One subject was found not to meet inclusion/exclusion criteria so subject was withdrawn and no data from this subject was evaluated.
93
Total93

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyProtocol Violation1

Baseline characteristics

CharacteristicIntended Users of the System
Age, Customized38.3 years
Region of Enrollment
United States
93 participants
Sex: Female, Male
Female
42 Participants
Sex: Female, Male
Male
51 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
7 / 94
serious
Total, serious adverse events
0 / 94

Outcome results

Primary

Numbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 20mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method

Subjects with diabetes tested subject fingerstick blood using an investigational blood glucose monitoring system (BGMS), which included an investigational meter and sensor. BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 20 mg/dL (for reference BG results \<75mg/dL) or +/- 5 to 20% (for reference BG results \>=75mg/dL) of the reference method results.

Time frame: 2 hours

Population: One subject was withdrawn from the study. One subject YSI reference sample was misidentified. Two subjects were not in steady state, required for the study. Four subjects' blood test data were thus not evaluable. The remaining 90 subjects tested 2 test strip lots on the BGMsystem. 2x90(180) test results were available.

ArmMeasureGroupValue (NUMBER)
Intended Users of the SystemNumbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 20mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-15mg/dL(<75mg/dL) or 20% (>=75mg/dL)180 Number of BG test results
Intended Users of the SystemNumbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 20mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-15mg/dL(<75mg/dL) or 15% (>=75mg/dL)179 Number of BG test results
Intended Users of the SystemNumbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 20mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-10mg/dL(<75mg/dL) or 10% (>=75mg/dL)172 Number of BG test results
Intended Users of the SystemNumbers of Fingerstick Blood Glucose (BG) Results Within +/- 5 to 20mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-5mg/dL(<75mg/dL) or 5% (>=75mg/dL)138 Number of BG test results
Secondary

Number of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)

Subjects reviewed the instructions for use (User Guide and Quick Reference Guide) to learn to use the system. Study staff then observed and rated the subjects (1 to 4) on their success at performing the tasks. Scale: 1.Success in performing tasks correctly without assistance. 2.Successful with additional review of User Guide. 3.Successful with additional review and study staff assist similar to review of a specific function during a Customer Service call. 4.Subject did not perform task correctly and study staff intervention was required.

Time frame: 2 hours

Population: For alternate-site palm and forearm testing tasks, 3 subjects with nonevaluable blood glucose data were not included. Only 90 participants were rated for those particular tasks.

ArmMeasureGroupValue (NUMBER)
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Turn meter on/off93 participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Date and time set on meter93 participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Normal control testing93 participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Subject blood testing - fingerstick93 participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Subject blood testing - palm (of 90)90 participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Subject blood testing - forearm (of 90)90 participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Comprehension)Understand underfill / ability to apply more blood93 participants
Secondary

Numbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method

Subjects with diabetes used an investigational blood glucose monitoring system (BGMS) with subject capillary blood obtained from the forearm. BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 20 mg/dL (for reference BG results \<75mg/dL) or +/- 5% to 20% (for reference BG results \>=75mg/dL) of the reference method results.

Time frame: 2 hours

Population: Since forearm testing by 5 hypoglycemic subjects (low blood glucose) was not allowed per the protocol, forearm data were not obtained/not evaluable for these subjects. Of the remaining 85 subjects, 83 tested 2 test strip lots(83x2) and 2 subjects tested 1 strip lot(2x1). A total of 168(166+2)test results were available.

ArmMeasureGroupValue (NUMBER)
Intended Users of the SystemNumbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-15mg/dL(<75mg/dL) or 20% (>=75mg/dL)158 Number of BG test results
Intended Users of the SystemNumbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-15mg/dL(<75mg/dL) or 15% (>=75mg/dL)145 Number of BG test results
Intended Users of the SystemNumbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-10mg/dL(<75mg/dL) or 10% (>=75mg/dL)125 Number of BG test results
Intended Users of the SystemNumbers of Forearm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-5mg/dL(<75mg/dL) or 5% (>=75mg/dL)74 Number of BG test results
Secondary

Numbers of Palm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method

Subjects with diabetes used an investigational blood glucose monitoring system (BGMS) with subject capillary blood obtained from the palm. BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 5 to 20 mg/dL (for reference BG results \<75mg/dL) or +/- 5% to 20% (for reference BG results \>=75mg/dL) of the reference method results.

Time frame: 2 hours

Population: Five subjects were hypoglycemic (low blood glucose value). Since alternate-site palm testing by these subjects was not allowed in the study, palm data from these five subjects were not obtained/ not evaluable. The remaining 85 subjects tested 2 test strip lots on the BGM system. 2x85(170)test results were available.

ArmMeasureGroupValue (NUMBER)
Intended Users of the SystemNumbers of Palm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-10mg/dL(<75mg/dL) or 10% (>=75mg/dL)143 Number of BG test results
Intended Users of the SystemNumbers of Palm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-15mg/dL(<75mg/dL) or 20% (>=75mg/dL)166 Number of BG test results
Intended Users of the SystemNumbers of Palm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-15mg/dL(<75mg/dL) or 15% (>=75mg/dL)161 Number of BG test results
Intended Users of the SystemNumbers of Palm Blood Glucose (BG) Results Within +/- 5 to 20 mg/dL (<75 mg/dL) or Within +/- 5% to 20% (>=75 mg/dL) of Laboratory Glucose Method# within +/-5mg/dL(<75mg/dL) or 5% (>=75mg/dL)82 Number of BG test results

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026